Skip to main content

Business

By Jessica Hagen | 11:57 am | December 12, 2025
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
By HIMSS TV | 09:38 am | December 12, 2025
Sandra Johnson, CliniComp senior vice president, says keeping data in a single longitudinal system makes it easier to prove AI's positive impact on metrics such as shorter stays, fewer readmissions and higher patient satisfaction.
By Jessica Hagen | 01:35 pm | December 11, 2025
Genentech will leverage Medra's Physical AI, Scientific AI and robotics into its lab systems to accelerate drug discovery.
By Jessica Hagen | 12:11 pm | December 10, 2025
The report shows that enterprise AI adoption has surged, with healthcare among the fastest‑growing sectors at 8x year‑over‑year adoption.
By Jessica Hagen | 10:53 am | December 10, 2025
CLEAR's biometric ID verification will be added to Welldoc's cardiometabolic care app, a move the companies say supports federal efforts to build a more connected health ecosystem.
By HIMSS TV | 10:28 am | December 10, 2025
Sam Davis Jr., in the second part of our interview, says meeting regularly with surgical staff and building trust in its predictive analytics helped Rush University Medical Center enhance OR efficiency and forecast surgical demand with 90% accuracy.
By Nathan Eddy | 10:13 am | December 09, 2025
Investors are funneling capital into early-stage automation and clinical support tools that use AI to counter workforce shortages, according to the report.
By Jessica Hagen | 04:38 pm | December 08, 2025
According to healthcare leaders, 2025 was a pivotal year for AI and digital health, marked by technological progress, a shifting focus on its role in healthcare and practical use cases driving its adoption.
By Jessica Hagen | 03:00 pm | December 08, 2025
The company will use the funds to advance product innovation, strengthen clinical partnerships and accelerate its nationwide growth.
By Jessica Hagen | 01:04 pm | December 08, 2025
Alongside the acquisition, the two companies entered a multi-year partnership to cross-integrate their platforms, aiming to expand access to clinical trials.